The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance

• George E. Duran ,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft

  * E-mail: george.duran@stanford.edu

  Affiliation Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, California, United States of America

  http://orcid.org/0000-0003-2692-3906

  ⨯
• Branimir I. Sikic

  Roles Funding acquisition, Methodology, Supervision, Writing – review & editing

  Affiliation Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯